Whitefort Capital Management »

Esperion Therapeutics shares owned by Whitefort Capital Management

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Whitefort Capital Management from 13F filings

Historical chart of Whitefort Capital Management investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Whitefort Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Whitefort Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.6M 886k 2.99

More positions owned by Whitefort Capital Management

Global Ship Lease Com Cl A (GSL)
Arbutus Biopharma (ABUS)
Roivant Sciences SHS (ROIV)
Liberty Media Corp Del Com Lbty Srm S C (LSXMK)
Nextnav Common Stock (NN)
Genworth Finl Com Cl A (GNW)
Sabre Glbl Note 4.000% 4/1 (Principal)
Maiden Holdings SHS (MHLD)
Liberty Media Corp Del Com Lbty Liv S C (LLYVK)
Central Europe and Russia Fund (CEE)
Esperion Therapeutics Inc Ne Note 4.000% 11/1 (Principal)
Liquidia Corporation Com New (LQDA)
Esperion Therapeutics (ESPR)
Odyssey Marine Expl Com New (OMEX)
Innovate Corp Note 7.500% 8/0 (Principal)

View all positions for Whitefort Capital Management

Top funds holding Esperion Therapeutics

Daniel D. Thurber
Vanguard Group
Bellevue Group
Meditor
Millennium Management
Two Sigma Investments
Two Sigma Advisers
Jpmorgan Chase & Co
Tang Capital Management
D. E. Shaw & Co
Walleye Trading
GSA Capital Partners
Schonfeld Strategic Advisors
Jacobs Levy Equity Management
Goldman Sachs Group

View all funds holding Esperion Therapeutics